ID: ALA540282

Max Phase: Preclinical

Molecular Formula: C26H31ClF2N4O2

Molecular Weight: 468.55

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cl.O=C1CNC(=O)N1CCCCCCN1CC[C@@H]2c3cc(F)ccc3N(c3ccc(F)cc3)[C@H]2C1

Standard InChI:  InChI=1S/C26H30F2N4O2.ClH/c27-18-5-8-20(9-6-18)32-23-10-7-19(28)15-22(23)21-11-14-30(17-24(21)32)12-3-1-2-4-13-31-25(33)16-29-26(31)34;/h5-10,15,21,24H,1-4,11-14,16-17H2,(H,29,34);1H/t21-,24+;/m1./s1

Standard InChI Key:  LHJGMBPSLULHJD-WKDBURHASA-N

Associated Targets(non-human)

Dopamine receptor 1304 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Rattus norvegicus 775804 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 468.55Molecular Weight (Monoisotopic): 468.2337AlogP: 4.39#Rotatable Bonds: 8
Polar Surface Area: 55.89Molecular Species: BASEHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.32CX Basic pKa: 9.42CX LogP: 4.00CX LogD: 1.99
Aromatic Rings: 2Heavy Atoms: 34QED Weighted: 0.46Np Likeness Score: -1.04

References

1. Sarges R, Howard HR, Donahue KM, Welch WM, Dominy BW, Weissman A, Koe BK, Bordner J..  (1986)  Neuroleptic activity of chiral trans-hexahydro-gamma-carbolines.,  29  (1): [PMID:3941416] [10.1021/jm00151a002]

Source